{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:59:33Z","timestamp":1790873973833,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.2353\/ajpath.2006.041310","type":"journal-article","created":{"date-parts":[[2007,3,16]],"date-time":"2007-03-16T19:40:05Z","timestamp":1174074005000},"page":"991-1003","source":"Crossref","is-referenced-by-count":12,"title":["Laminin \u03b12 Chain-Positive Vessels and Epidermal Growth Factor in Lung Neuroendocrine Carcinoma"],"prefix":"10.1016","volume":"168","author":[{"given":"Domenico","family":"Vitolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Ciocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Deriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Masuelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Morrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jo","family":"Filice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio Furio","family":"Coloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Giorgio","family":"Natali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Davide","family":"Baroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2006.041310_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1044-579X(02)00023-8","article-title":"Laminin isoforms in tumor invasion, angiogenesis and metastasis","volume":"12","author":"Patarroyo","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"10.2353\/ajpath.2006.041310_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/dbio.1997.8668","article-title":"Developmental regulation of the laminin \u03b15 chain suggests a role in epithelial and endothelial cell maturation","volume":"189","author":"Sorokin","year":"1997","journal-title":"Dev Biol"},{"key":"10.2353\/ajpath.2006.041310_bib3","doi-asserted-by":"crossref","first-page":"15854","DOI":"10.1074\/jbc.273.25.15854","article-title":"Isolation and characterization of laminin-10\/11 secreted by human lung carcinoma cells\u2014laminin-10\/11 mediates cell adhesion through integrin \u03b13\u03b21","volume":"25","author":"Kikkawa","year":"1998","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2006.041310_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/excr.1999.4399","article-title":"Expression of laminins 1 and 10 in carcinoma cells and comparison of their roles in cell adhesion","volume":"248","author":"Tani","year":"1999","journal-title":"Exp Cell Res"},{"key":"10.2353\/ajpath.2006.041310_bib5","first-page":"896","article-title":"Expression of the gamma(2) chain of laminin-5 at the invasive front is associated with recurrence and poor prognosis in human esophageal squamous cell carcinoma","volume":"7","author":"Yamamoto","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.2353\/ajpath.2006.041310_bib6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/ijc.1539","article-title":"Laminin-5 in the progression of carcinomas","volume":"94","author":"Lohi","year":"2001","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2006.041310_bib7","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1073\/pnas.85.5.1544","article-title":"Merosin, a protein specific for basement membranes of Schwann cells, striate muscle and trophoblast, is expressed late in nerve and muscle development","volume":"85","author":"Leivo","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.041310_bib8","first-page":"426","article-title":"Distribution of merosin, a laminin-related tissue-specific basement membrane protein, in human Schwann cell neoplasms","volume":"61","author":"Leivo","year":"1989","journal-title":"Lab Invest"},{"key":"10.2353\/ajpath.2006.041310_bib9","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1073\/pnas.87.9.3264","article-title":"Merosin, a tissue specific basement membrane protein, is a laminin-like protein","volume":"87","author":"Ehrig","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.041310_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1172\/JCI115565","article-title":"Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway in vivo","volume":"89","author":"Damsky","year":"1992","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2006.041310_bib11","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1083\/jcb.134.6.1483","article-title":"Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival","volume":"134","author":"Vachon","year":"1996","journal-title":"J Cell Biol"},{"key":"10.2353\/ajpath.2006.041310_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1097-0029(20000201\/15)48:3\/4<181::AID-JEMT6>3.0.CO;2-Q","article-title":"Merosin and congenital muscular dystrophy","volume":"48","author":"Miyagoe-Suzuki","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.2353\/ajpath.2006.041310_bib13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2559.1996.d01-471.x","article-title":"Expression of adhesion molecules and extracellular matrix proteins in glioblastomas: relation to angiogenesis and spread","volume":"28","author":"Vitolo","year":"1996","journal-title":"Histopathology"},{"key":"10.2353\/ajpath.2006.041310_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/path.938","article-title":"Laminin \u03b12 chain (merosin M chain) distribution and VEGF, FGF2 and TGF\u03b21 gene expression in angiogenesis of supraglottis, lung and breast carcinomas","volume":"195","author":"Vitolo","year":"2001","journal-title":"J Pathol"},{"key":"10.2353\/ajpath.2006.041310_bib15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.3748\/wjg.v9.i6.1144","article-title":"Mechanism and its regulation of tumor-induced angiogenesis","volume":"9","author":"Gupta","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.2353\/ajpath.2006.041310_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/(SICI)1096-9896(199908)188:4<369::AID-PATH381>3.0.CO;2-X","article-title":"Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-FLT1 and VEGF-R2-KDR) in non-small cell lung carcinomas: correlation with angiogenesis and survival","volume":"188","author":"Decaussin","year":"1999","journal-title":"J Pathol"},{"key":"10.2353\/ajpath.2006.041310_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<281::AID-PATH527>3.0.CO;2-Z","article-title":"Molecular mechanisms that control endothelial cell contacts","volume":"190","author":"Vesweber","year":"2000","journal-title":"J Pathol"},{"key":"10.2353\/ajpath.2006.041310_bib18","series-title":"Atlas of Tumor Pathology, third series, fascicle 13","first-page":"235","article-title":"Tumors of the lower respiratory tract","author":"Colby","year":"1995"},{"key":"10.2353\/ajpath.2006.041310_bib19","series-title":"Atlas of Tumor Pathology, third series, fascicle 26","first-page":"45","article-title":"Tumors of the upper aerodigestive tract and ear","author":"Mills","year":"2000"},{"key":"10.2353\/ajpath.2006.041310_bib20","series-title":"Atlas of Tumor Pathology, third series, fascicle 7","first-page":"157","article-title":"Tumors of the mammary gland","author":"Roset","year":"1993"},{"key":"10.2353\/ajpath.2006.041310_bib21","series-title":"Histological Typing of Lung and Pleural Tumors","article-title":"In Collaboration with Sobin LH and Pathologists in 14 Countries","author":"Travis","year":"1999"},{"key":"10.2353\/ajpath.2006.041310_bib22","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1002\/eji.1830231020","article-title":"Regulation of CD59 expression on the human endothelial cell line EA.hy 926","volume":"23","author":"Meri","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.2353\/ajpath.2006.041310_bib23","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/sj.onc.1202442","article-title":"Immune responses to all ErbB family receptors detectable in serum of cancer patients","volume":"18","author":"Bei","year":"1999","journal-title":"Oncogene"},{"key":"10.2353\/ajpath.2006.041310_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.2001.5197","article-title":"Laminin-10 mediate basal and EGF-stimulate motility of human colon carcinoma cells via alpha (3) beta (1) and alpha (6) beta (4) integrins","volume":"266","author":"Pouliot","year":"2001","journal-title":"Exp Cell Res"},{"key":"10.2353\/ajpath.2006.041310_bib25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrc1094","article-title":"Basement membranes: structure, assembly and role in tumour angiogenesis","volume":"3","author":"Kalluri","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.2353\/ajpath.2006.041310_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-5793(97)00412-2","article-title":"The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions","volume":"410","author":"Alroy","year":"1997","journal-title":"FEBS Lett"},{"key":"10.2353\/ajpath.2006.041310_bib27","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/emboj\/19.13.3159","article-title":"The ErbB signaling network: receptor heterodimerizaton in development and cancer","volume":"19","author":"Olayioye","year":"2000","journal-title":"EMBO J"},{"key":"10.2353\/ajpath.2006.041310_bib28","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/bjc.1998.553","article-title":"In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor","volume":"78","author":"Damstrup","year":"1998","journal-title":"Br J Cancer"},{"key":"10.2353\/ajpath.2006.041310_bib29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/jnci\/90.11.824","article-title":"Levels of TGF-\u03b1 and EGFR protein in head and neck squamous cell carcinoma and patient survival","volume":"90","author":"Grandis","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.2353\/ajpath.2006.041310_bib30","first-page":"3579","article-title":"Elevated levels of transforming growth factor \u03b1 and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck","volume":"53","author":"Grandis","year":"1993","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2006.041310_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1083\/jcb.200207138","article-title":"EGF controls the in vivo developmental potential of a mammary epithelial cell line possessing progenitor properties","volume":"159","author":"Deugnier","year":"2002","journal-title":"J Cell Biol"},{"key":"10.2353\/ajpath.2006.041310_bib32","first-page":"2379","article-title":"Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung","volume":"53","author":"Rusch","year":"1993","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2006.041310_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/028418602753669481","article-title":"Growth factor-induced cell motility in tumor invasion","volume":"41","author":"Wells","year":"2002","journal-title":"Acta Oncol"},{"key":"10.2353\/ajpath.2006.041310_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijc.1572","article-title":"Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype","volume":"97","author":"Damstrup","year":"2002","journal-title":"Int J Cancer"},{"key":"10.2353\/ajpath.2006.041310_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000012166","article-title":"Growth characteristics of rectal carcinoid tumors","volume":"59","author":"Shimizu","year":"2000","journal-title":"Oncology"},{"key":"10.2353\/ajpath.2006.041310_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/sonc.2002.31520","article-title":"Epidermal growth factor receptor family in lung cancer and premalignancy","volume":"29","author":"Franklin","year":"2002","journal-title":"Semin Oncol"},{"key":"10.2353\/ajpath.2006.041310_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0027-5107(01)00201-9","article-title":"The role of alpha 6 beta 1 integrin and EGF in normal and malignant acinar morpho-genesis of human prostatic epithelium","volume":"480\u2013481","author":"Bello-DeOcampo","year":"2001","journal-title":"Mutat Res"},{"key":"10.2353\/ajpath.2006.041310_bib38","first-page":"361","article-title":"Colon cancer cells adhesion and spreading on autocrine laminin-10 is mediated by multiple integrin receptors and modulated by EGF receptor stimulation","volume":"188","author":"Poullot","year":"1999","journal-title":"J Pathol"},{"key":"10.2353\/ajpath.2006.041310_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1091\/mbc.4.1.121","article-title":"Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology","volume":"4","author":"Goldman","year":"1993","journal-title":"Mol Biol Cell"},{"key":"10.2353\/ajpath.2006.041310_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s102380200009","article-title":"Effect of epidermal growth factor on vascular endothelial growth factor secretion by endometrial stromal cells","volume":"2","author":"Kawano","year":"2002","journal-title":"Clin Exp Med"},{"key":"10.2353\/ajpath.2006.041310_bib41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1634\/theoncologist.7-suppl_4-2","article-title":"Why the epidermal growth factor receptor? The rationale for cancer therapy","volume":"7","author":"Baselga","year":"2002","journal-title":"Oncologist"},{"key":"10.2353\/ajpath.2006.041310_bib42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.2003.10.104","article-title":"Evaluation on monoclonal humanized anti-HER 2 antibody, Trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group","volume":"21","author":"Bookman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.2353\/ajpath.2006.041310_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000227677","article-title":"Suramin inhibits the growth of non-small-cell cancer cells that express the epidermal growth factor receptor","volume":"54","author":"Fujiuchi","year":"1997","journal-title":"Oncology"},{"key":"10.2353\/ajpath.2006.041310_bib44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/sonc.2002.35646","article-title":"Epidermal growth factor receptor expression, signal pathway inhibitors in non-small cell lung cancer","volume":"29","author":"Bunn","year":"2002","journal-title":"Semin Oncol"},{"key":"10.2353\/ajpath.2006.041310_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1278-3218(03)00019-2","article-title":"Epidermal growth factor receptors (EGFR): a new target for anticancer therapy","volume":"7","author":"Gainet","year":"2003","journal-title":"Cancer Radiother"},{"key":"10.2353\/ajpath.2006.041310_bib46","first-page":"4593","article-title":"Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders","volume":"57","author":"Presta","year":"1997","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2006.041310_bib47","first-page":"5209","article-title":"Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors","volume":"59","author":"Prewett","year":"1999","journal-title":"Cancer Res"},{"key":"10.2353\/ajpath.2006.041310_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI8829","article-title":"Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity","volume":"105","author":"Klement","year":"2000","journal-title":"J Clin Invest"},{"key":"10.2353\/ajpath.2006.041310_bib49","doi-asserted-by":"crossref","first-page":"11393","DOI":"10.1073\/pnas.172398299","article-title":"VEGF-trap: a VEGF blocker with potent antitumor effects","volume":"99","author":"Holash","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.2353\/ajpath.2006.041310_bib50","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa021491","article-title":"A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer","volume":"349","author":"Yang","year":"2003","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2006.041310_bib51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1200\/JCO.2003.10.066","article-title":"Phase II, randomized trial comparing bevacizumab plus fluorouracil(FU)\/leucovorin(LV) with FU\/LV alone in patients with metastatic colorectal cancer","volume":"21","author":"Kabbinavar","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401062158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000294401062158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T19:23:49Z","timestamp":1546975429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000294401062158X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S000294401062158X"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2006.041310","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}